May 9, 2022
Tumors can force neighboring cells into supporting cancer growth by releasing lactate into their local environment, according to researchers at Weill Cornell Medicine. The findings pave the way for future drug treatments that thwart that defense mechanism to help cancer patients.
March 19, 2022
Please join us in welcoming our incoming WCM Pathology Residency Class of 2022-2026! Uzayr Arif, DOUzayr will receive his DO from New York Institute of Technology College of Osteopathic Medicine, with and undergraduate degree in Life Sciences from New York Institute of Technology. Uzayr is an incoming AP/CP resident.Robert Chen, MD/PhDRobert will receive his MD from Emory University School of Medicine and his PhD in Computer Science from the Georgia Institute of Technology, with an undergraduate degree from the Massachusetts Institute of Technology. He was awarded the Young Investigators...
March 10, 2022
Two multi-institutional teams led by Weill Cornell Medicine scientists have been awarded grant support from the Starr Cancer Consortium. Both grants will fund work applying new technologies to develop more detailed knowledge of tumor biology, with one team focusing on Hodgkin lymphoma and the other on the purity of tumor samples on pathology slides.
February 16, 2022
A specific group of fungi residing in the intestines can protect against intestinal injury and influence social behavior, according to new preclinical research by scientists at Weill Cornell Medicine. The findings extend a growing body of work identifying a "gut-immunity-brain axis," a signaling system that may have a wide range of effects on physiology in both health and disease, influenced not only by the body's own cells but also the resident microbes.The study, published Feb. 16 in Cell, reveals a novel set of molecular signals connecting fungi in the gut to their host’s cells throughout...
January 26, 2022
Read the latest WCM Pathology Newsletter to learn more about our Research Highlights, Scholarly Advances, new faculty and much more. You can also read our past issues here.
January 20, 2022
Dear Pathology and Laboratory Medicine Family, As you may have heard, the blood supply in New York City is at a crisis level and it is National Blood Donor Month. Due to the pandemic, and the inability to host blood drives, the New York City Blood Center currently has a 1-2 day supply. Within transfusion medicine, there are daily discussions as to the ability to supply elective surgeries with blood products. Close to 2000 donations are needed each day in the NY/NJ community for patients who require a lifesaving blood and/or platelet transfusion. In addition to using restrictive blood...
December 6, 2021
Clinical laboratories are unsung heroes of COVID-19In normal times, clinical laboratories, including pathologists, laboratory directors and clinical laboratory scientists, function in the background. We are not patient facing but provide important diagnostic tools and insights to our partner physicians and nurses. In a war analogy, we are the code breakers that support the front-line troops. Pathology is detective work, investigating the best test, understanding regulations, and figuring out the diagnosis in a timely manner. COVID-19 thrust laboratory professionals into the unknown with an...
November 17, 2021
The American Association for Cancer Research (AACR) today announced the appointment of Massimo Loda, MD, as the Editor-in-Chief of Molecular Cancer Research, one of the nine highly esteemed journals published by the AACR. Loda officially began his term on August 1.Massimo Loda, MDChairman of Pathology and Laboratory MedicineMolecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. The journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insights into pathways and processes...
November 17, 2021
Dr. C. Richard Minick (1936-2021), Professor Emeritus of Pathology and Laboratory Medicine at Weill Cornell Medicine, Cornell University, died on Long Island, New York on November 5, 2021 at the age of 85. Dr. Minick will be remembered for his extraordinary contributions to the role of cell injury and inflammation in the pathogenesis of atherosclerosis. His innovative work helped to focus scientific research on the role of immunological and viral injury in the development of cardiovascular disease. Dr. Minick published 42 substantive research papers and 19 book chapters in the field of...
September 28, 2021
Convalescent plasma did not reduce the risk of intubation or death for hospitalized COVID-19 patients in a large, international clinical trial conducted by Weill Cornell Medicine and NewYork-Presbyterian investigators in collaboration with lead investigators at McMaster University.